Target intelligence / Profile preview

Protein deglycase DJ-1 (DJ-1) (DJ-1)

Target
DJ-1
Molecular classification
Enzyme, Transcription factor, Other
01

Overview

Protein deglycase DJ-1, encoded by the PARK7 gene, is a ubiquitous and multifunctional protein essential for cellular protection against oxidative stress and mitochondrial dysfunction (UniProt P59998). It functions primarily as a redox-sensitive chaperone and an enzyme that repairs glycated proteins, thereby preventing the accumulation of advanced glycation end-products (PubMed: 28106294). In the context of neurodegeneration, particularly Parkinson's disease, loss-of-function mutations in DJ-1 lead to early-onset pathology, making the restoration of its activity a primary therapeutic goal (PubMed: 12446770). Current research focuses on the DJ-1 pathway via gene overexpression using viral vectors to increase protein levels in the substantia nigra, aiming to provide neuroprotection and reduce alpha-synuclein toxicity (PubMed: 31430310). While promising for neurodegenerative disorders, the therapeutic application must be balanced against DJ-1's role as an oncogene, where its overexpression is associated with increased cell proliferation and resistance to apoptosis in various cancers (PubMed: 19249685). Consequently, therapeutic strategies must carefully titrate DJ-1 levels to achieve neuroprotection without inducing malignant transformation. Small molecule stabilizers and inducers are also being explored to enhance the endogenous activity of the DJ-1 pathway.

Other names
Parkinson disease protein 7PARK7Protein DJ-1RNA-binding protein 7Maillard deglycase
02

Mechanism of action

Gene overexpression to increase protein levels and enhance antioxidant/chaperone activity; stabilization of the DJ-1 homodimer to maintain functional integrity.

03

Biological functions

Signal transductionApoptosisCell deathOther
04

Disease associations

CancerNeurodegenerative diseaseOther
05

Safety considerations

Potential oncogenic activity due to cell survival promotionImmunogenicity of viral delivery vectorsRisk of off-target gene integrationDifficulty in regulating precise protein expression levels
06

Interacting drugs

AAV-DJ-1

3 more in the full profile.

07

Biomarkers

Cerebrospinal fluid DJ-1 levelsPlasma DJ-1 levelsOxidized DJ-1 (Cys106-SO3H)Alpha-synuclein aggregation

Beyond the preview

Go deeper on Protein deglycase DJ-1 (DJ-1) (DJ-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein deglycase DJ-1 (DJ-1) (DJ-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call